Pioglitazone

Better Known as: Actos

• Marketed By: Takeda Pharmaceuticals
  
• Major Indication: Hypoglycemia & Type 2 Diabetes
  
• Drug Class: PPAR-γ Activator - Thiazolidinedione (Glitazones)
• Date of FDA Approval (Patent Expiration): 1999 (2011)
  
• 2009 Sales: $2.4 Billion
• Why You Should Care: It is the best selling drug to treat Diabetes and is the 10th best selling drug in the United States.
• The following is a list of Pharmacokinetic Parameters. See: Pharmaceutical Drugs for more information

Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky